Volume 26, Issue 4, Pages (April 2007)

Slides:



Advertisements
Similar presentations
Constitutively Active β-Catenin Confers Multilineage Differentiation Potential on Lymphoid and Myeloid Progenitors  Yoshihiro Baba, Karla P. Garrett,
Advertisements

Volume 17, Issue 1, Pages (July 2015)
Volume 14, Issue 1, Pages (January 2014)
Volume 22, Issue 6, Pages (February 2018)
Volume 3, Issue 6, Pages (June 2013)
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Volume 6, Issue 4, Pages (April 1997)
Volume 4, Issue 4, Pages (August 2013)
Volume 38, Issue 6, Pages (June 2013)
Volume 30, Issue 4, Pages (April 2009)
Volume 6, Issue 1, Pages (January 2016)
Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells
Volume 8, Issue 5, Pages (May 2011)
Volume 3, Issue 5, Pages (November 2014)
Volume 126, Issue 2, Pages (July 2006)
The Placenta Is a Niche for Hematopoietic Stem Cells
Volume 35, Issue 3, Pages (September 2011)
Volume 29, Issue 2, Pages (August 2008)
Volume 8, Issue 4, Pages (April 2011)
Volume 2, Issue 4, Pages (April 2008)
Volume 4, Issue 2, Pages (February 2003)
Georges Lacaud, Leif Carlsson, Gordon Keller  Immunity 
Acquisition of a Functional T Cell Receptor during T Lymphocyte Development Is Enforced by HEB and E2A Transcription Factors  Mary Elizabeth Jones, Yuan.
Volume 22, Issue 4, Pages e4 (April 2018)
Volume 29, Issue 1, Pages (July 2008)
Volume 121, Issue 2, Pages (April 2005)
Volume 13, Issue 5, Pages (November 2013)
Volume 37, Issue 5, Pages (November 2012)
Kenichi Miharada, Valgardur Sigurdsson, Stefan Karlsson  Cell Reports 
Motonari Kondo, Irving L. Weissman, Koichi Akashi  Cell 
Volume 14, Issue 12, Pages (March 2016)
Volume 29, Issue 2, Pages (August 2008)
Volume 16, Issue 5, Pages (November 2009)
Volume 43, Issue 2, Pages (August 2015)
Volume 12, Issue 4, Pages (April 2013)
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Volume 9, Issue 1, Pages (July 2011)
Volume 21, Issue 1, Pages (July 2004)
Volume 36, Issue 2, Pages (February 2012)
Volume 10, Issue 5, Pages (May 2012)
Volume 2, Issue 4, Pages (April 2014)
Volume 15, Issue 3, Pages (April 2016)
Volume 38, Issue 5, Pages (May 2013)
Volume 9, Issue 4, Pages (November 2014)
Volume 28, Issue 4, Pages (April 2008)
Identification of a T Lineage-Committed Progenitor in Adult Blood
Volume 11, Issue 3, Pages (September 2012)
Volume 16, Issue 12, Pages (September 2016)
Volume 45, Issue 2, Pages (August 2016)
Masayuki Yamashita, Eriko Nitta, Toshio Suda  Cell Stem Cell 
Volume 5, Issue 5, Pages (November 2015)
Volume 6, Issue 3, Pages (March 2010)
Volume 4, Issue 2, Pages (February 2009)
Volume 17, Issue 4, Pages (October 2002)
Volume 15, Issue 4, Pages (October 2001)
Volume 1, Issue 6, Pages (December 2007)
Volume 24, Issue 1, Pages (January 2006)
Volume 1, Issue 6, Pages (December 2007)
Kiran Batta, Magdalena Florkowska, Valerie Kouskoff, Georges Lacaud 
Volume 24, Issue 6, Pages (June 2006)
Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 
Volume 8, Issue 1, Pages (January 2011)
Volume 4, Issue 4, Pages (August 2013)
Volume 1, Issue 2, Pages (August 2007)
Volume 17, Issue 4, Pages (October 2015)
SLAM Family Markers Resolve Functionally Distinct Subpopulations of Hematopoietic Stem Cells and Multipotent Progenitors  Hideyuki Oguro, Lei Ding, Sean J.
Volume 8, Issue 6, Pages (June 2017)
Tomokatsu Ikawa, Hiroshi Kawamoto, Lilyan Y.T. Wright, Cornelis Murre 
Volume 20, Issue 6, Pages (June 2004)
Volume 6, Issue 4, Pages (April 1997)
Presentation transcript:

Volume 26, Issue 4, Pages 407-419 (April 2007) Molecular Evidence for Hierarchical Transcriptional Lineage Priming in Fetal and Adult Stem Cells and Multipotent Progenitors  Robert Månsson, Anne Hultquist, Sidinh Luc, Liping Yang, Kristina Anderson, Shabnam Kharazi, Suleiman Al-Hashmi, Karina Liuba, Lina Thorén, Jörgen Adolfsson, Natalija Buza-Vidas, Hong Qian, Shamit Soneji, Tariq Enver, Mikael Sigvardsson, Sten Eirik W. Jacobsen  Immunity  Volume 26, Issue 4, Pages 407-419 (April 2007) DOI: 10.1016/j.immuni.2007.02.013 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 Distinct Multilineage Reconstitution Patterns of FL LSK Subsets (A) Boxes denote the sorting strategy used for each of the LSKCD34loFLT3−, LSKCD34hiFLT3−, LSKCD34+FLT3lo, and LSKCD34+FLT3hi populations (numbers indicate percentages of total FL cells), resulting in 96% or higher purity (right, composite figure of reanalysis of 4 populations). (B) Lethally irradiated C57Bl/6 mice were transplanted with 40 cells of each LSK subpopulation in competition with 200,000 unfractionated BM cells. Panels show mean ± SD percent contribution toward total, myeloid, B cell, and T cell reconstitution in peripheral blood derived from transplanted LSKCD34loFLT3−, LSKCD34hiFLT3− (divided into mice revealing LT-HSC activity and no LT-HSC activity), LSKCD34+FLT3lo, and LSKCD34+FLT3hi cells at 3, 5, 7, and 16 weeks after transplantation. Numbers indicate the frequencies of reconstituted mice at 3 and 16 weeks after transplantation (next to graphs), as well as frequencies of mice reconstituted at any time point (far right). (C) Total and myeloid reconstitution of secondary recipients 12 weeks after transplantation of half a femur equivalent of BM cells from primary recipients with long-term multilineage reconstitution. Graphs show the mean ± SD percent, and numbers indicate frequency of reconstituted mice. Immunity 2007 26, 407-419DOI: (10.1016/j.immuni.2007.02.013) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 LSKCD34+ FL Cells Lose MkE Potential upon Upregulation of FLT3 Expression Single FL LSKCD34loFLT3− (A), LSKCD34hiFLT3− (B), LSKCD34+FLT3lo (C), and LSKCD34+FLT3hi (D) cells were evaluated for their potential to develop Mk, E, G, M, B, and T cells in vitro. The potentials were investigated at multiple time points to best establish the optimal timing for each lineage and cell population (Experimental Procedures). Based on this, Mk and E potentials were evaluated at day 8 for LSKCD34loFLT3− and LSKCD34hiFLT3− cells and at day 6 for LSKCD34+FLT3lo and LSKCD34+FLT3hi cells, whereas GM potential was evaluated at day 12 for LSKCD34loFLT3− cells, day 10 for LSKCD34hiFLT3− cells, and day 6 for LSKCD34+FLT3lo and LSKCD34+FLT3hi cells. Open bars show frequencies of clones formed and closed bars show frequencies of cells with indicated lineage potential. Mean ± SEM percent values from 3–6 experiments. Also shown are representative FACS profiles defining B cell (B220+CD19+) and T cell (NK1.1−Thy1.2hiCD25hi) potentials, as well as representative cell morphology pictures from the GM and Mk culture conditions. Immunity 2007 26, 407-419DOI: (10.1016/j.immuni.2007.02.013) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 3 Single LSKCD34+FLT3hi FL Cells Have Combined B, T, and GM Potentials (A) Experimental design (for details see Experimental Procedures). (B) Frequencies of single LSKCD34+FLT3hi cells possessing different lineage potentials based on FACS and morphology. Mean ± SEM percent values from four experiments. Numbers shown in brackets denote the total number of clones with the specified lineage combinations. (C) A single representative BTM clone analyzed by FACS and morphology having combined B, T, and GM potential. All lineages were confirmed with lineage-specific gene-expression analysis (Table S1, clone 9). FACS profiles show representative myeloid cells (MAC-1+ and negative for CD19, NK1.1, CD3, CD4, CD8, CD25, and Thy1.2), B cells (CD19+), and T cells (NK1.1−Thy1.2hiCD25hi). (D) NK cell potential (NK1.1+DX5+CD3− and/or NK1.1+B220+CD3−) of single FL LSKCD34+FLT3hi cells grown for 14 days on OP9 in the presence of KL, FLT3L, and IL-7. Open bar shows cloning frequency and closed bar frequency of cells with NK potential. Representative FACS profiles are shown. Mean ± SEM percent values from four experiments. Immunity 2007 26, 407-419DOI: (10.1016/j.immuni.2007.02.013) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 4 Hierarchical Clustering of MkE, GM, and Lymphoid-Associated Genes in Adult BM LMPPs and HSCs Clusters show MkE, GM, and lymphoid-associated genes having an expression of ≥50 units in at least one LSK subpopulation and being regulated ≥2-fold between any two LSK subpopulations. Note that expression levels are not directly comparable between MG-U74Av2 and MOE430 2.0 chip data. Red indicates high, blue low, and white intermediate expression levels. (For complete lists of lineage-associated genes and cluster with indicated expression values, see Figure S6.) Immunity 2007 26, 407-419DOI: (10.1016/j.immuni.2007.02.013) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 5 Expression Levels of MkE, GM, and Lymphoid Genes in Adult BM LMPPs and HSCs Quantitative PCR analysis of expression of MkE (A), GM (B), B and T cell (C), and common lymphoid (D) genes in FACS-purified BM LSKCD34−FLT3− LT-HSCs (LT), LSKCD34+FLT3− ST-HSCs (ST), and LSKCD34+FLT3hi LMPPs (LMPP). BM Lin− KIT+ cells (containing progenitor cells of different lineages), BM CD43+AA4.1+CD19+ (pro-B) cells, and CD4+CD8+ thymocytes were used as controls. All data were normalized to the expression of hypoxanthine guanine phosphoribosyl transferase 1 (Hprt1). Mean ± SEM percent values from at least two different sorts. Q-PCR measurements were done in triplicates. 0 = no detectable expression after 45 cycles of PCR. Mean differences between LSK subsets higher than 2-fold are indicated. ND = not done. Immunity 2007 26, 407-419DOI: (10.1016/j.immuni.2007.02.013) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 6 Hierarchical Coexpression Patterns of MkE, GM, and Lymphoid Lineage Programs in Adult LSK Subsets (A) Distribution of lineage programs. (B) Coexpression of Mpl with different lineage programs. Open bars show frequencies of cells within each LSK population having indicated lineage priming, and black bars frequencies of cells coexpressing specific lineage programs and Mpl. Expression of Kit served as an internal positive control for the RT-PCR, thus only cells being Kit mRNA positive were further analyzed (typically ∼90% of investigated BM LSK cells). Cells were scored as expressing MkE, GM, and/or lymphoid programs based on the expression of one or more lineage-associated genes: MkE, Gata1, Vwf, and Epor; GM, Csf3r and Mpo; lymphoid, Rag1, sterile IgH transcript, and Il7r. Cells were, based on expressed programs, classified as: unprimed (unpr), having no lineage program; uni-lineage, having one program; bi-lineage, having any two programs; or multilineage, having all programs. Mean ± SEM percent values from two independent experiments with 88 single cells analyzed in each experiment. NA, nonapplicable (as no cells of indicated phenotype expressed the specified lineage program). Immunity 2007 26, 407-419DOI: (10.1016/j.immuni.2007.02.013) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 7 Hierarchical Organization of MkE, GM, and Lymphoid Programs within Distinct Fetal LSK Subpopulations Coexpression patterns of lineage programs in single cells from fetal LSK subpopulations. Cells were scored as expressing MkE, GM, and/or lymphoid programs based on the expression of one or more lineage-associated genes: MkE, Gata1, Vwf, and Epor; GM, Csf3r, and Mpo; lymphoid, Rag1, sterile IgH transcript, and Il7r. Mean ± SEM percent values from two to three independent experiments, with 88 cells of each population investigated in each experiment. Immunity 2007 26, 407-419DOI: (10.1016/j.immuni.2007.02.013) Copyright © 2007 Elsevier Inc. Terms and Conditions